Rklb stock

**Bottom-line: Rocket Lab (RKLB) is in a “wait-and-see” lull—price is hovering near $70 with a healthy $39.9 B market cap, but mixed signals from insiders, neutral technicals, and a hefty backlog keep the stock in a sideways groove rather than a full-blown rally.** 🚀🤔 |market_code|code|Ticker|Name|Date|Closing Price| |---|---|---|---|---|---| |186|RKLB|RKLB.O|Rocket Lab|20260310|70.65| |market_code|code|Ticker|Name|Date|Trading Volume| |---|---|---|---|---|---| |186|RKLB|RKLB.O|Rocket Lab|20260310|13820927| |market_code|code|Ticker|Name|Date|Market Cap| |---|---|---|---|---|---| |186|RKLB|RKLB.O|Rocket Lab|20250310|7.7646920264E9| |186|RKLB|RKLB.O|Rocket Lab|20250311|8.08670904385E9| |186|RKLB|RKLB.O|Rocket Lab|20250312|8.35883610085E9| |186|RKLB|RKLB.O|Rocket Lab|20250313|7.96878731915E9| |186|RKLB|RKLB.O|Rocket Lab|20250314|8.53118323695E9| |186|RKLB|RKLB.O|Rocket Lab|20250317|8.6627113145E9| |186|RKLB|RKLB.O|Rocket Lab|20250318|8.1547408081E9| |186|RKLB|RKLB.O|Rocket Lab|20250319|8.5175768841E9| |186|RKLB|RKLB.O|Rocket Lab|20250320|8.40419061035E9| |186|RKLB|RKLB.O|Rocket Lab|20250321|8.5901440993E9| --- ### 1. What the tape is telling us 📊✨ • Latest close: **$70.36** on **14.08 M shares**; market cap **$39.93 B**. • Day-traders saw a modest **-1.57 %** move, while pre-market quotes flirted with $72.07 (+0.83 %) and after-hours ticked to $71.67 (+0.27 %)—a classic “range-bound” session. • Momentum gauges are neutral: RSI 48.3, MACD −2.02, stoch 53.7—no strong buy or sell pressure yet. • Key levels to watch: **$80.00 resistance** and **$67.00 support**, per recent technical write-ups. 📈🔍 --- ### 2. Fundamentals: backlog > headlines 💼🛰️ • Q4-25 revenue hit **$179.65 M** with a **-$52.92 M** net loss (MRQ). • FY-25 revenue set a new record at **$602 M**, backlog swelling **73 % YoY to $1.85 B**. • Management guides Q1-26 revenue of **$185-200 M** and gross margin of **34-36 %**. • The Neutron rocket delay to Q4-26 is “priced-in,” but investors keep asking whether Electron can carry the load alone. 🛰️🛠️ |market_code|code|Ticker|Name|Date|Total Revenue|Net Income| |---|---|---|---|---|---|---| |186|RKLB|RKLB.O|Rocket Lab|2025 Q1|1.22569E8|-6.0616E7| |186|RKLB|RKLB.O|Rocket Lab|2025 Q2|1.44498E8|-6.6414E7| |186|RKLB|RKLB.O|Rocket Lab|2025 Q3|1.5508E8|-1.8257E7| |186|RKLB|RKLB.O|Rocket Lab|2025 Q4|1.79652E8|-5.2922E7| |market_code|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS| |---|---|---|---|---|---|---| |186|RKLB|RKLB.O|Rocket Lab|2025 Q1|-33.33333333333333|-0.12| |186|RKLB|RKLB.O|Rocket Lab|2025 Q2|-62.5|-0.13| |186|RKLB|RKLB.O|Rocket Lab|2025 Q3|70|-0.03| --- ### 3. Insider vs. institutional tug-of-war 👔🏦 • Lead independent director **Merline Saintil sold 18,126 shares at $75.04** on Mar-6. • CFO Adam Spice and other insiders off-loaded **4.34 M shares worth $279.7 M** in the last 90 days, yet institutions now own **~71.8 %** of the float. • Norges Bank, Invesco and others keep adding—suggesting long-term confidence despite the insider selling. 🤝📉 --- ### 4. Street view: lofty targets, mixed conviction 🎯🧐 | Latest Target | Date | Source | Tone | |---------------|------|--------|------| | $120 | 2026-01-20 | Unspecified | Very bullish | | $105 | 2026-01-16 | Morgan Stanley | Upgraded | | $75.92 | 2026-03-09 | Consensus | Moderate Buy | • Consensus rating: **“Moderate Buy”** with an average target of **$75.92**—about 8 % above today’s price. • Options flow shows heavy call activity into $75–$85 strikes expiring Mar-20 & Mar-27, hinting at a near-term price hinge. 📈💡 --- ### 5. 1–2 week trading game-plan 🗓️🎯 1. **Range trader:** Buy $69–$71, target $75, stop $67.50. 2. **Breakout chaser:** Add on a daily close > $75 with volume > 15 M; aim for $80, stop $72. 3. **Risk guardrail:** If price slips below $67, step aside—the technical floor is fragile. 🛡️ --- **Curious thought:** Given the tug-of-war between insider selling and institutional accumulation, are you more tempted to “go with the smart money” or “fade the insiders” and pick up shares at a discount? 🤔💬